Press Releases

Active Biotech’s rights issue heavily oversubscribed
January 26, 2021 11:00 (CET)
Adjustment of period for trading in subscription rights and interim shares in Active Biotech’s rights issue
January 7, 2021 14:15 (CET)
Regulatory
Active Biotech publishes prospectus and certain new financial information included in the prospectus
January 5, 2021 14:00 (CET)
Regulatory
Active Biotech Receive Milestone Payment From Neotx
December 11, 2020 12:00 (CET)
Regulatory
Active Biotech’s nomination committee appointed
December 1, 2020 16:45 (CET)
Regulatory
Report from extraordinary general meeting in Active Biotech and adjustment of previously communicated timetable for the rights issue
November 30, 2020 15:30 (CET)
Regulatory
Active Biotech announces the final terms of the rights issue
November 25, 2020 08:30 (CET)
Regulatory
Correction to previous pressrelease: Active Biotech updates its clinical strategy and projected milestones
November 24, 2020 11:50 (CET)
Regulatory
ACTIVE BIOTECH UPDATES ITS CLINICAL STRATEGY AND PROJECTED MILESTONES
November 24, 2020 08:00 (CET)
Regulatory
Invitation to Active Biotech’s virtual capital markets day
November 6, 2020 13:35 (CET)